Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol

References

• Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, Madhi SA, Omer SB, Simões EAF, Campbell H. et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399(10340):2047–10. doi:10.1016/S0140-6736(22)00478-0.
   PubMed Web of Science ®Google Scholar
• Blanken MO, Rovers MM, Molenaar JM, Winkler-Seinstra PL, Meijer A, Kimpen JL, Bont L. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med. 2013;368(19):1791–9. doi:10.1056/NEJMoa1211917.
   PubMed Web of Science ®Google Scholar
• Welliver RC. Respiratory syncytial virus and other respiratory viruses. Pediatr Infect Dis J. 2003;22(2 Suppl):S6–10. discussion S-2. doi:10.1097/01.inf.0000053880.92496.db.
   PubMed Web of Science ®Google Scholar
• Viguria N, Martinez-Baz I, Moreno-Galarraga L, Sierrasesumaga L, Salcedo B, Castilla J, Morrow BM. Respiratory syncytial virus hospitalization in children in northern Spain. PLoS One. 2018;13(11):e0206474. doi:10.1371/journal.pone.0206474.
   PubMed Web of Science ®Google Scholar
• Demont C, Petrica N, Bardoulat I, Duret S, Watier L, Chosidow A, Lorrot M, Kieffer A, Lemaitre M. Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018. BMC Infect Dis. 2021;21(1):730. doi:10.1186/s12879-021-06399-8.
   PubMed Web of Science ®Google Scholar
• Reeves RM, Hardelid P, Panagiotopoulos N, Minaji M, Warburton F, Pebody R. Burden of hospital admissions caused by Respiratory Syncytial Virus (RSV) in infants in England: a data linkage modelling study. J Infect. 2019;78(6):468–75. doi:10.1016/j.jinf.2019.02.012.
   PubMed Web of Science ®Google Scholar
• Mira-Iglesias A, Demont C, Lopez-Labrador FX, Mengual-Chulia B, Garcia-Rubio J, Carballido-Fernandez M, Tortajada‐Girbés M, Mollar‐Maseres J, Schwarz‐Chavarri G, Puig‐Barberà J. et al. Role of age and birth month in infants hospitalized with RSV-confirmed disease in the Valencia Region, Spain. Influenza Other Respir Viruses. 2022;16(2):328–39. doi:10.1111/irv.12937.
   PubMed Web of Science ®Google Scholar
• Martinon-Torres F, Carmo M, Platero L, Drago G, Lopez-Belmonte JL, Bangert M, Díez-Domingo J, Garcés-Sánchez M. Clinical and economic burden of respiratory syncytial virus in Spanish children: the BARI study. BMC Infect Dis. 2022;22(1):759. doi:10.1186/s12879-022-07745-0.
   PubMed Web of Science ®Google Scholar
• Gil-Prieto R, Gonzalez-Escalada A, Marin-Garcia P, Gallardo-Pino C, Gil-de-Miguel A. Respiratory syncytial virus bronchiolitis in children up to 5 years of age in Spain: epidemiology and comorbidities: an observational study. Medicine (Baltimore). 2015;94(21):e831. doi:10.1097/MD.0000000000000831.
   PubMed Web of Science ®Google Scholar
• Heppe-Montero M, Walter S, Hernandez-Barrera V, Gil-Prieto R, Gil-de-Miguel A. Burden of respiratory syncytial virus-associated lower respiratory infections in children in Spain from 2012 to 2018. BMC Infect Dis. 2022;22(1):315. doi:10.1186/s12879-022-07261-1.
   PubMed Web of Science ®Google Scholar
• Langedijk AC, Bont LJ. Respiratory syncytial virus infection and novel interventions. Nat Rev Microbiol. 2023;21(11):734–49. doi:10.1038/s41579-023-00919-w.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Beyfortus nirsevimab. 2023 Jan 30. https://www.ema.europa.eu/en/medicines/human/EPAR/beyfortus#ema-inpage-item-authorisation-details.
   Google Scholar
• Government of Canada. Drug product database. 2024 Mar 14. https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102594.
   Google Scholar
• Food and Drug Administration (FDA). FDA approves new drug to prevent RSV in babies and toddlers. 2023. https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-prevent-rsv-babies-and-toddlers.
   Google Scholar
• Martinon-Torres F, Miras-Carballal S, Duran-Parrondo C. Early lessons from the implementation of universal respiratory syncytial virus prophylaxis in infants with long-acting monoclonal antibodies, Galicia, Spain, September and October 2023. Euro Surveill. 2023;28(49). doi:10.2807/1560-7917.ES.2023.28.49.2300606.
   PubMedGoogle Scholar
• Martinon-Torres F, Navarro-Alonso JA, Garces-Sanchez M, Soriano-Arandes A. The path towards effective respiratory syncytial virus immunization policies: recommended actions. Arch Bronconeumol. 2023;59(9):581–8. doi:10.1016/j.arbres.2023.06.006.
   PubMed Web of Science ®Google Scholar
• NIRSE-GAL. Evaluación de la efectividad e impacto de Nirsevimab en Galicia 2023. 2024. https://www.nirsegal.es/.
   Google Scholar
• Galician Statistical Institute [Instituto Galego de Estadística]. 2024 Mar 24. https://www.ige.gal/.
   Google Scholar
• Galician Health Service (SERGAS). Activities report SERGAS 2018. [Memoria actividades SERGAS 2018] 2018 [accessed 2024 Feb 20]. https://www.sergas.es/A-nosa-organizacion/Documents/832/MemoriaActividade2018.pdf.
   Google Scholar
• Government of Spain-Ministry of Health [Ministerio de Sanidad]. Vaccination information system [Sistema de Información de Vacunaciones (SIVAMIN)]. 2022. https://pestadistico.inteligenciadegestion.sanidad.gob.es/publicoSNS/I/sivamin/informe-de-evolucion-de-coberturas-de-vacunacion-por-vacuna.
   Google Scholar
• Galician Health Service (SERGAS). Respiratoty syncital virus [virus sincitial respiratorio]. 2024 Mar 24. https://www.sergas.es/Saude-publica/Virus-Sincitial-Respiratorio?idioma=es.
   Google Scholar
• Estatistica IGd. Hospitais [hospitals] 2022. https://www.ige.gal/web/mostrar_actividade_estatistica.jsp?idioma=gl&codigo=0202001.
   Google Scholar
• Galician Health Service (SERGAS). Hospitals. 2024. https://www.sergas.es/bucen/busca-hospitais.
   Google Scholar
• Olsen SJ, Winn AK, Budd AP, Prill MM, Steel J, Midgley CM, Kniss K, Burns E, Rowe T, Foust A. et al. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic — United States, 2020–2021. MMWR Morb Mortal Wkly Rep. 2021;70(29):1013–19. doi:10.15585/mmwr.mm7029a1.
   PubMed Web of Science ®Google Scholar
• Simoes EAF, Madhi SA, Muller WJ, Atanasova V, Bosheva M, Cabanas F, Baca Cots M, Domachowske JB, Garcia-Garcia ML, Grantina I. et al. Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials. Lancet Child Adolesc Health. 2023;7(3):180–9. doi:10.1016/S2352-4642(22)00321-2.
   PubMedGoogle Scholar
• Muller WJ, Madhi SA, Seoane Nunez B, Baca Cots M, Bosheva M, Dagan R, Hammitt LL, Llapur CJ, Novoa JM, Saez Llorens X. et al. Nirsevimab for prevention of RSV in term and late-preterm infants. N Engl J Med. 2023;388(16):1533–4. doi:10.1056/NEJMc2214773.
   PubMed Web of Science ®Google Scholar
• Hammitt LL, Dagan R, Yuan Y, Baca Cots M, Bosheva M, Madhi SA, Muller WJ, Zar HJ, Brooks D, Grenham A. et al. Nirsevimab for prevention of RSV in healthy late-preterm and term infants. N Engl J Med. 2022;386(9):837–46. doi:10.1056/NEJMoa2110275.
   PubMed Web of Science ®Google Scholar
• Griffin MP, Yuan Y, Takas T, Domachowske JB, Madhi SA, Manzoni P, Simões EAF, Esser MT, Khan AA, Dubovsky F. et al. Single-dose nirsevimab for prevention of RSV in preterm infants. N Engl J Med. 2020;383(5):415–25. doi:10.1056/NEJMoa1913556.
   PubMed Web of Science ®Google Scholar
• Domachowske J, Madhi SA, Simoes EAF, Atanasova V, Cabanas F, Furuno K, Garcia-Garcia ML, Grantina I, Nguyen KA, Brooks D. et al. Safety of nirsevimab for RSV in infants with heart or lung disease or prematurity. N Engl J Med. 2022;386(9):892–4. doi:10.1056/NEJMc2112186.
   PubMed Web of Science ®Google Scholar
• Galician Health Service (SERGAS). Pharmacovigilance security [Seguridad Pharmacovigilancia]. https://www.sergas.gal/Saude-publica/Seguridade-e-farmacovixilancia?idioma=es.
   Google Scholar
• Galician Health Service (SERGAS). Circulation of the respiratory syncytial virus in Galicia: validity of the wave threshold. Revision 2023 [Circulación do virus respiratorio sincitial en Galicia: validez do limiar de onda. Revisión 2023]. Boletín Epidemiolóxico de Galicia. 2023;XXXII(6):1–16. https://www.sergas.es/Saude-publica/Documents/7294/BEG%20XXXII-6.pdf.
   Google Scholar
• Ranganathan P, Pramesh CS, Aggarwal R. Common pitfalls in statistical analysis: absolute risk reduction, relative risk reduction, and number needed to treat. Perspect Clin Res. 2016;7(1):51–3. doi:10.4103/2229-3485.173773.
   PubMedGoogle Scholar
• Galician Statistical Institute [Instituto Galego de Estadistica]. 2024. https://www.ige.gal/web/mostrar_seccion.jsp?idioma=gl&codigo=0201.
   Google Scholar
• Homaira N, Briggs N, Oei JL, Hilder L, Bajuk B, Jaffe A, Omer SB. Association of age at first severe respiratory syncytial virus disease with subsequent risk of severe asthma: a population-based cohort study. J Infect Dis. 2019;220(4):550–6. doi:10.1093/infdis/jiy671.
   PubMed Web of Science ®Google Scholar
• Szabo SM, Levy AR, Gooch KL, Bradt P, Wijaya H, Mitchell I. Elevated risk of asthma after hospitalization for respiratory syncytial virus infection in infancy. Paediatr Respir Rev. 2013;13(2):S9–15. doi:10.1016/S1526-0542(12)70161-6.
   PubMedGoogle Scholar
• de Miguel Diez J, Lopez de Andres A, Jimenez Garcia R. The Minimum Basic Data Set (MBDS), our big data for the epidemiological investigation of respiratory diseases. Arch Bronconeumol (Engl Ed). 2020;56(5):267–8. doi:10.1016/j.arbr.2019.04.022.
   PubMed Web of Science ®Google Scholar
• Baldassarre ME, Loconsole D, Centrone F, Caselli D, Martire B, Quartulli L, Acquafredda A, D’Amato G, Maffei G, Latorre G. et al. Hospitalization for bronchiolitis in children aged ≤ 1year, Southern Italy, year 2021: need for new preventive strategies? Ital J Pediatr. 2023;49(1):66. doi:10.1186/s13052-023-01455-2.
   PubMed Web of Science ®Google Scholar